Mylan has been in the news for hiking prices on its EpiPen. The stock is flat since we recommended it in March, but we now ...

the stock price ended up going down, to close at Rs 4,094.55 on the BSE. Pfizer also informed that this agreement has been made for a period of 5 years and within the Indian territory. Mylan has a ...

You'd think one scandal would be enough. Mylan, the company that came under fire this summer for systematically raising the price of the EpiPen, is caught up in another drug price scheme.

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.